CD177 and breast cancer: Using the germline Cd177-KO mice17, we found that Cd177-deficiency led to a significant decrease in tumor growth from the Py8119 orthotopic breast cancer model (Fig. 5a, female mice) or the MC38 colon cancer model (Fig. 5b, male mice).